NeutraKine® TGF beta 1 Monoclonal antibody

NeutraKine® TGF beta 1 Monoclonal Antibody for IHC, ELISA, Neutralization

Host / Isotype

Mouse / IgG1


Human and More (1)


IHC, ELISA, Neutralization





Cat no : 69012-1-Ig


TGFB1, TGFB1,TGF beta 1,TGFbeta,TGF-beta 1, TGF-beta1, TGFB, tgf beta1


Product Information

69012-1-Ig targets NeutraKine® TGF beta 1 in IHC, ELISA, Neutralization applications and shows reactivity with Human samples.

Tested Reactivity Human
Cited Reactivityhuman
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Immunogen human Humankine TGF beta 1 protein HZ-1011
Full Name transforming growth factor, beta 1
Gene Symbol TGFB1
Gene ID (NCBI) 7040
Conjugate Unconjugated
Form Lyophilized Powder
Purification MethodProtein G purification
Storage Buffer Sterile PBS.
Endotoxin<0.1 EU/μg
ReconstitutionThis product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use.
Stability and StorageLyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products.

Background Information

TGFB, also named as LAP and TGFB1, is a multifunctional peptide that controls proliferation, differentiation, and other functions in many cell types. TGFB acts synergistically with TGFA in inducing transformation. It also acts as a negative autocrine growth factor. Dysregulation of TGFB activation and signaling may result in apoptosis. Many cells synthesize TGFB and almost all of them have specific receptors for it. TGFB positively and negatively regulates many other growth factors. It plays an important role in bone remodeling as it is a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts. It is highly expressed in bone. Mutation of TGFB are the cause of Camurati-Engelmann disease (CED) which known as progressive diaphyseal dysplasia 1 (DPD1).

This antibody can be used to neutralize the bioactivity of TGF beta 1.


Product Specific Protocols
IHC protocol for NeutraKine® TGF beta 1 antibody 69012-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols




Emodin suppresses hepatocellular carcinoma growth by regulating macrophage polarization via microRNA-26a/transforming growth factor beta 1/protein kinase B.

Authors - Jiao Yin

Cell Death Discov

A positive feedback loop: RAD18-YAP-TGF-β between triple-negative breast cancer and macrophages regulates cancer stemness and progression.

Authors - Xueqi Yan


Co-transplantation of autologous Treg cells in a cell therapy for Parkinson's disease

Authors - Tae-Yoon Park

Stem Cell Res Ther

Blockade of TGF-β signalling alleviates human adipose stem cell senescence induced by native ECM in obesity visceral white adipose tissue

Authors - Xueya Han